BioSpace News Archive

Marketing, Program Management, Clinical Services and Global Clinical Quality.

RTB101 10 mg once daily was observed to reduce the rate of laboratory-confirmed Respiratory Tract Infections (RTIs) by 78.7% (p=0.001) and the rate of all RTIs (with or without laboratory confirmation) by 66.4% (p=0.003) as compared to placebo among Phase 2b participants 65 years of age and older with asthma

The American Academy of Pediatric Dentistry announced the rebranding of Healthy Smiles, Healthy Children, its charitable arm, as the AAPD Foundation.

Texas-based health plan using new capabilities to create sustainable system that provides choice, control, and access to vulnerable populations

This partnership paves way for new opportunities for medical education in the Kansas region

In the booming industry of hemp-based products, one new company, CBD Choice, is setting itself apart from the others through a dedication to quality ingredients, scientific expertise, and first-rate customer service.

Winners honored at luncheon event recognizing healthcare trailblazers

Inhibrx, Inc. announced that it has entered into an agreement with Viking Global Investors LP for the offering and sale of convertible promissory notes in a private placement transaction in the aggregate principal amount of $40 million.

Aerin Medical, Inc. announced that it closed on a $50 million non-dilutive term loan agreement with CRG LP, a healthcare focused investment firm.

Results Delivered in Oral Presentation at Digestive Disease Week 2019